Stem Cell Therapeutics
Toronto
About Stem Cell Therapeutics
Stem Cell Therapeutics Corp. (TSX-V: SSS), a Toronto-based biopharmaceutical development company, is Canada’s only public company dedicated to advancing cancer stem cell discoveries into novel and innovative cancer therapies. Building on over half a century of leading groundbreaking Canadian stem cell research, we are supported by established links to multiple Toronto academic institutes and oncology treatment centres that represent one of the world’s most acclaimed cancer research hubs.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $33.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2013)
- Ticker: tsx:SSS
- Website: stemcellthera.com
- Phone: +1 416.595.0627
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Canonical: https://fsome.com/organization/stem-cell-therapeutics-2270929 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.